216 related articles for article (PubMed ID: 33230203)
1. ERICH3: vesicular association and antidepressant treatment response.
Liu D; Zhuang Y; Zhang L; Gao H; Neavin D; Carrillo-Roa T; Wang Y; Yu J; Qin S; Kim DC; Liu E; Nguyen TTL; Biernacka JM; Kaddurah-Daouk R; Dunlop BW; Craighead WE; Mayberg HS; Binder EB; Frye MA; Wang L; Weinshilboum RM
Mol Psychiatry; 2021 Jun; 26(6):2415-2428. PubMed ID: 33230203
[TBL] [Abstract][Full Text] [Related]
2. Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction.
Nguyen TTL; Liu D; Ho MF; Athreya AP; Weinshilboum R
Front Pharmacol; 2020; 11():614048. PubMed ID: 33510640
[TBL] [Abstract][Full Text] [Related]
3. TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.
Gupta M; Neavin D; Liu D; Biernacka J; Hall-Flavin D; Bobo WV; Frye MA; Skime M; Jenkins GD; Batzler A; Kalari K; Matson W; Bhasin SS; Zhu H; Mushiroda T; Nakamura Y; Kubo M; Wang L; Kaddurah-Daouk R; Weinshilboum RM
Mol Psychiatry; 2016 Dec; 21(12):1717-1725. PubMed ID: 26903268
[TBL] [Abstract][Full Text] [Related]
4. The ERICH3 rs11580409 polymorphism is associated with 6-month antidepressant response in depressed patients.
Chappell K; Colle R; Ait Tayeb AEK; Bouligand J; El-Asmar K; Deflesselle E; Fève B; Becquemont L; Corruble E; Verstuyft C
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Dec; 119():110608. PubMed ID: 35878676
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication.
Athreya AP; Neavin D; Carrillo-Roa T; Skime M; Biernacka J; Frye MA; Rush AJ; Wang L; Binder EB; Iyer RK; Weinshilboum RM; Bobo WV
Clin Pharmacol Ther; 2019 Oct; 106(4):855-865. PubMed ID: 31012492
[TBL] [Abstract][Full Text] [Related]
6. Plasma serotonin levels are associated with antidepressant response to SSRIs.
Holck A; Wolkowitz OM; Mellon SH; Reus VI; Nelson JC; Westrin Å; Lindqvist D
J Affect Disord; 2019 May; 250():65-70. PubMed ID: 30831543
[TBL] [Abstract][Full Text] [Related]
7. The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.
Biernacka JM; Sangkuhl K; Jenkins G; Whaley RM; Barman P; Batzler A; Altman RB; Arolt V; Brockmöller J; Chen CH; Domschke K; Hall-Flavin DK; Hong CJ; Illi A; Ji Y; Kampman O; Kinoshita T; Leinonen E; Liou YJ; Mushiroda T; Nonen S; Skime MK; Wang L; Baune BT; Kato M; Liu YL; Praphanphoj V; Stingl JC; Tsai SJ; Kubo M; Klein TE; Weinshilboum R
Transl Psychiatry; 2015 Apr; 5(4):e553. PubMed ID: 25897834
[TBL] [Abstract][Full Text] [Related]
8. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
[TBL] [Abstract][Full Text] [Related]
9. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
[TBL] [Abstract][Full Text] [Related]
10. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
[TBL] [Abstract][Full Text] [Related]
11. Altered serotonergic circuitry in SSRI-resistant major depressive disorder patient-derived neurons.
Vadodaria KC; Ji Y; Skime M; Paquola AC; Nelson T; Hall-Flavin D; Heard KJ; Fredlender C; Deng Y; Elkins J; Dani K; Le AT; Marchetto MC; Weinshilboum R; Gage FH
Mol Psychiatry; 2019 Jun; 24(6):808-818. PubMed ID: 30903001
[TBL] [Abstract][Full Text] [Related]
12. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk.
Srivastava A; Singh P; Gupta H; Kaur H; Kanojia N; Guin D; Sood M; Chadda RK; Yadav J; Vohora D; Saso L; Kukreti R
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018568
[TBL] [Abstract][Full Text] [Related]
13. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
14. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
16. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder.
Papakostas GI; Fava M
Eur Neuropsychopharmacol; 2007 Jan; 17(1):32-6. PubMed ID: 16762534
[TBL] [Abstract][Full Text] [Related]
18. [Fluoxetine: an update of its use in major depressive disorder in adults].
Gourion D; Perrin E; Quintin P
Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
[TBL] [Abstract][Full Text] [Related]
19. Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons.
Vadodaria KC; Ji Y; Skime M; Paquola A; Nelson T; Hall-Flavin D; Fredlender C; Heard KJ; Deng Y; Le AT; Dave S; Fung L; Li X; Marchetto MC; Weinshilboum R; Gage FH
Mol Psychiatry; 2019 Jun; 24(6):795-807. PubMed ID: 30700803
[TBL] [Abstract][Full Text] [Related]
20. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
